Nothing Special   »   [go: up one dir, main page]

DE60043889D1 - Tet repressor basierte transkriptionale regulatorische proteine - Google Patents

Tet repressor basierte transkriptionale regulatorische proteine

Info

Publication number
DE60043889D1
DE60043889D1 DE60043889T DE60043889T DE60043889D1 DE 60043889 D1 DE60043889 D1 DE 60043889D1 DE 60043889 T DE60043889 T DE 60043889T DE 60043889 T DE60043889 T DE 60043889T DE 60043889 D1 DE60043889 D1 DE 60043889D1
Authority
DE
Germany
Prior art keywords
tetracycline
transkriptionale
regulatorische
basierte
proteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60043889T
Other languages
English (en)
Inventor
Wolfgang Hillen
Hermann Bujard
Stefanie Urlinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TET Systems Holding GmbH and Co KG
Original Assignee
TET Systems Holding GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22479925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60043889(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by TET Systems Holding GmbH and Co KG filed Critical TET Systems Holding GmbH and Co KG
Application granted granted Critical
Publication of DE60043889D1 publication Critical patent/DE60043889D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60043889T 1999-06-07 2000-06-05 Tet repressor basierte transkriptionale regulatorische proteine Expired - Fee Related DE60043889D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13798699P 1999-06-07 1999-06-07
PCT/IB2000/000886 WO2000075347A2 (en) 1999-06-07 2000-06-05 Tet repressor-based transcriptional regulatory proteins

Publications (1)

Publication Number Publication Date
DE60043889D1 true DE60043889D1 (en) 2010-04-08

Family

ID=22479925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60043889T Expired - Fee Related DE60043889D1 (en) 1999-06-07 2000-06-05 Tet repressor basierte transkriptionale regulatorische proteine

Country Status (8)

Country Link
US (1) US7541446B2 (de)
EP (1) EP1200607B1 (de)
JP (1) JP4836375B2 (de)
AT (1) ATE458818T1 (de)
AU (1) AU783233B2 (de)
CA (1) CA2376665C (de)
DE (1) DE60043889D1 (de)
WO (1) WO2000075347A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030186281A1 (en) * 2001-12-21 2003-10-02 Wolfgang Hillen Modified tetracycline repressor protein compositions and methods of use
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8039587B2 (en) 2003-10-24 2011-10-18 Gencia Corporation Methods and compositions for delivering polynucleotides
WO2006037215A1 (en) * 2004-10-04 2006-04-13 National Research Council Of Canada Expression system, components thereof and methods of use
US7935788B2 (en) * 2004-10-04 2011-05-03 National Research Council Of Canada Reverse cumate repressor mutant
US9068969B2 (en) * 2004-12-28 2015-06-30 Ptc Therapeutics, Inc. Cell based methods and systems for the identification of RNA regulatory sequences and compounds that modulate their functions
JP4944781B2 (ja) 2005-09-15 2012-06-06 独立行政法人科学技術振興機構 テトラサイクリン系抗生物質によるタンパク質分解制御法
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
JP2009537139A (ja) * 2006-05-15 2009-10-29 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を制御する方法
EP2043662B1 (de) * 2006-07-26 2015-09-09 Intrexon Corporation Verfahren und zusammensetzungen zur behandlung von krankheiten
EP2135945B1 (de) 2007-03-14 2014-04-23 Japan Science and Technology Agency Verfahren zur doppelten regulation von transkription/abbau für ein protein mittels antibiotikum
US20080235746A1 (en) 2007-03-20 2008-09-25 Michael James Peters Methods and apparatus for content delivery and replacement in a network
WO2010037593A1 (en) 2008-10-01 2010-04-08 Tet Systems Holding Gmbh & Co.Kg Tetracycline inducible transcription control sequence
US8257956B2 (en) 2008-10-28 2012-09-04 E. I. Du Pont De Nemours And Company Sulfonylurea-responsive repressor proteins
US9866609B2 (en) 2009-06-08 2018-01-09 Time Warner Cable Enterprises Llc Methods and apparatus for premises content distribution
MX2012012211A (es) * 2010-04-23 2012-12-17 Du Pont Composiciones de interruptores genicos y metodos de uso de las mismas.
EP2643459B1 (de) * 2010-11-24 2017-09-27 Takara Bio USA, Inc. Transkriptionsmodulatoren mit einem system für induzierbare expression und einer domäne für verteilte proteintransduktion
JP2014506458A (ja) * 2011-01-26 2014-03-17 クロンテック・ラボラトリーズ・インコーポレーテッド タンパク質形質導入の向上
US9822379B2 (en) 2011-05-19 2017-11-21 Fundación Pública Andaluza Progreso Y Salud Highly inducible dual-promoter lentiviral TET-ON system
SG10201606970UA (en) 2012-02-23 2016-10-28 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
US20180245038A1 (en) 2015-09-04 2018-08-30 Universita' Degli Studi Di Padova Method for generating somatic stem cells
CN108474002B (zh) 2015-10-22 2023-05-23 朱诺治疗学有限公司 用于转导的方法、反应剂盒、反应剂和设备
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
WO2017205852A2 (en) 2016-05-27 2017-11-30 Synthex, Inc. Protein interfaces
US10687115B2 (en) 2016-06-01 2020-06-16 Time Warner Cable Enterprises Llc Cloud-based digital content recorder apparatus and methods
US10129593B2 (en) 2017-03-14 2018-11-13 Charter Communications Operating, Llc Time-based dynamic secondary content placement calls in time-shifted content
SG11201909931PA (en) 2017-04-27 2019-11-28 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
GB2584210B (en) 2017-11-22 2022-03-16 Synthex Inc Peptides for inhibiting RAD51
US10939142B2 (en) 2018-02-27 2021-03-02 Charter Communications Operating, Llc Apparatus and methods for content storage, distribution and security within a content distribution network
CN113584083A (zh) 2020-04-30 2021-11-02 深圳市深研生物科技有限公司 用于逆转录病毒载体的生产细胞和包装细胞及其制备方法
CN113699147B (zh) 2020-05-22 2023-06-09 深圳市深研生物科技有限公司 基于四环素和Cumate的共调控序列
US11566262B2 (en) 2021-03-24 2023-01-31 Dna Twopointo Inc. Tetracycline-inducible expression systems
CN114134160B (zh) * 2021-12-04 2024-01-09 安徽大学 一种四环素调控蛋白突变体基因及其在调控基因表达和环境检测中的应用
US20240228561A1 (en) 2023-01-06 2024-07-11 Life Biosciences, Inc. Methods Of Treating Non-Arteritic Anterior Ischemic Optic Neuropathy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004672A1 (en) * 1992-08-26 1994-03-03 Dnx Corp. Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals
US5464758A (en) * 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5589362A (en) * 1993-06-14 1996-12-31 Basf Aktiengesellschaft Tetracycline regulated transcriptional modulators with altered DNA binding specificities
US5650298A (en) * 1993-06-14 1997-07-22 Basf Aktiengesellschaft Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor
US6004941A (en) * 1993-06-14 1999-12-21 Basf Aktiengesellschaft Methods for regulating gene expression
DE4417598A1 (de) * 1994-05-19 1995-12-14 Max Planck Gesellschaft Verwendung des Tetracyclinpromotors zur stringent regulierten Produktion von rekombinanten Proteinen in prokaryontischen Zellen
US5851796A (en) * 1995-06-07 1998-12-22 Yale University Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
US6087166A (en) * 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
DE19851415B4 (de) 1998-11-07 2010-11-04 Wolfgang Hillen Mutanter Transaktivator
DE19851413C2 (de) 1998-11-07 2003-05-22 Wolfgang Hillen Verfahren zur Auswahl von Mutanten von tTA oder rtTA

Also Published As

Publication number Publication date
JP4836375B2 (ja) 2011-12-14
AU5419100A (en) 2000-12-28
WO2000075347A2 (en) 2000-12-14
US20030208783A1 (en) 2003-11-06
EP1200607A2 (de) 2002-05-02
JP2003515314A (ja) 2003-05-07
ATE458818T1 (de) 2010-03-15
AU783233B2 (en) 2005-10-06
EP1200607B1 (de) 2010-02-24
CA2376665C (en) 2014-02-25
CA2376665A1 (en) 2000-12-14
US7541446B2 (en) 2009-06-02
WO2000075347A3 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
DE60043889D1 (en) Tet repressor basierte transkriptionale regulatorische proteine
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
MX339420B (es) Compuestos para la modulacion de la actividad de ppar gamma.
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
ZA9710796B (en) Oxyiminopregnanecarbolactones.
NZ324921A (en) Cathepsin K crystal structure and methods of identifying inhibitors of this protease
DE69110771D1 (de) Stahlkabel zur Verstärkung von elastomeren Erzeugnissen.
GB9003939D0 (en) Sulphatase inhibitors
PT1165115E (pt) Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2
DE59803538D1 (de) Wässerige dispersionen enthaltend polyurethane mit carbodiimidgruppen
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE69612440D1 (de) Rührbioreaktor
TR199800854T2 (xx) Antis�tma kinolin t�revleri.
ZA938823B (en) Bioreactor with immobilized lactic acid bacteria and the use thereof.
NO175313C (no) Joderte polymerer og deres anvendelse
DK0652964T3 (da) Promotor af K. lactis transaldolasegenet og anvendelse heraf
TW430629B (en) Display panel production line
DK0633928T3 (da) Mikroorganismer, deres fremstilling og anvendelse
DK0656889T3 (da) 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk
ATE140730T1 (de) Dns-segmente und das delta-1 des hydrogenasegen enthaltende mikroorganismen und ihre verwendung
AU1829599A (en) Bacterial fibrin-dependent plasminogen activator
Gleick et al. Segregation anxiety.
Holden Don't call it shop.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee